126 related articles for article (PubMed ID: 32354925)
1. Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer.
Rades D; Nguyen T; Schild SE
In Vivo; 2020; 34(3):1321-1324. PubMed ID: 32354925
[TBL] [Abstract][Full Text] [Related]
2. Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary.
Rades D; Nguyen T; Khoa MT; Janssen S; Schild SE
Anticancer Res; 2020 Apr; 40(4):2261-2264. PubMed ID: 32234923
[TBL] [Abstract][Full Text] [Related]
3. An Instrument for Estimating the 6-Month Survival Probability After Whole-brain Irradiation Alone for Cerebral Metastases from Gynecological Cancer.
Janssen S; Hansen HC; Schild SE; Rades D
Anticancer Res; 2018 Jun; 38(6):3753-3756. PubMed ID: 29848738
[TBL] [Abstract][Full Text] [Related]
4. A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation.
Nguyen T; Bartscht T; Schild SE; Rades D
Anticancer Res; 2020 Mar; 40(3):1661-1664. PubMed ID: 32132071
[TBL] [Abstract][Full Text] [Related]
5. An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer.
Rades D; Nguyen T; Janssen S; Schild SE
Anticancer Res; 2020 Apr; 40(4):2257-2260. PubMed ID: 32234922
[TBL] [Abstract][Full Text] [Related]
6. The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer.
Rades D; Nguyen T; Schild SE
In Vivo; 2020; 34(3):1317-1320. PubMed ID: 32354924
[TBL] [Abstract][Full Text] [Related]
7. Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder.
Rades D; Dziggel L; Manig L; Janssen S; Khoa MT; Duong VN; Khiem VH; Schild SE
In Vivo; 2018; 32(3):633-636. PubMed ID: 29695570
[TBL] [Abstract][Full Text] [Related]
8. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
[TBL] [Abstract][Full Text] [Related]
9. Predicting survival after whole-brain irradiation for cerebral metastases from prostate cancer.
Bartscht T; Rades D
Anticancer Res; 2014 Aug; 34(8):4357-60. PubMed ID: 25075071
[TBL] [Abstract][Full Text] [Related]
10. A Simple Implement for Assessing the Survival of Elderly Patients With Melanoma Irradiated for Cerebral Metastases.
Nguyen T; Janssen S; Schild SE; Rades D
In Vivo; 2020; 34(3):1361-1364. PubMed ID: 32354931
[TBL] [Abstract][Full Text] [Related]
11. A new score predicting survival prognosis after whole-brain radiotherapy alone for brain metastases in elderly patients.
Evers JN; Schild SE; Segedin B; Nagy V; Khoa MT; Trang NT; Rades D
Anticancer Res; 2014 May; 34(5):2455-8. PubMed ID: 24778060
[TBL] [Abstract][Full Text] [Related]
12. Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer.
Nguyen T; Bartscht T; Schild SE; Rades D
Anticancer Res; 2020 Mar; 40(3):1665-1668. PubMed ID: 32132072
[TBL] [Abstract][Full Text] [Related]
13. A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone.
Huttenlocher S; Dziggel L; Hornung D; Blanck O; Schild SE; Rades D
Radiat Oncol; 2014 Sep; 9():215. PubMed ID: 25240823
[TBL] [Abstract][Full Text] [Related]
14. A new tool to predict survival after radiosurgery alone for newly diagnosed cerebral metastases.
Rades D; Huttenlocher S; Dziggel L; Blanck O; Hornung D; Mai KT; Ngo TT; Van Pham T; Schild S
Asian Pac J Cancer Prev; 2015; 16(7):2967-70. PubMed ID: 25854390
[TBL] [Abstract][Full Text] [Related]
15. Development of a Survival Score for Patients with Cerebral Metastases from Melanoma.
Sehmisch L; Schild SE; Rades D
Anticancer Res; 2017 Jan; 37(1):249-252. PubMed ID: 28011499
[TBL] [Abstract][Full Text] [Related]
16. Predictive Factors for Local Control and Survival in Patients with Cancer of Unknown Primary (CUP) Irradiated for Cerebral Metastases.
Rades D; Dziggel L; Janssen S; Khoa MT; Duong VN; Khiem VH; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 Apr; 38(4):2415-2418. PubMed ID: 29599370
[TBL] [Abstract][Full Text] [Related]
17. Predicting Survival After Irradiation for Brain Metastases from Head and Neck Cancer.
Rades D; Dziggel L; Hakim SG; Rudat V; Janssen S; Trang NT; Khoa MT; Bartscht T
In Vivo; 2015; 29(5):525-8. PubMed ID: 26359409
[TBL] [Abstract][Full Text] [Related]
18. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
[TBL] [Abstract][Full Text] [Related]
19. Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.
Huttenlocher S; Sehmisch L; Schild SE; Blank O; Hornung D; Rades D
Anticancer Res; 2014 Oct; 34(10):5589-92. PubMed ID: 25275060
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the Six-month Survival Probability After Radiosurgery for Brain Metastases from Kidney Cancer.
Janssen S; Dahlke M; Trang NT; Khoa MT; Rades D
Anticancer Res; 2015 Jul; 35(7):4215-7. PubMed ID: 26124381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
